Sumitomo Pharma Co Ltd 2024 Other Report
The report presents fiscal 2024 KPI results across product development, human capital, human rights, and environmental initiatives. It reports a 36% reduction in Scope 1+2 GHG emissions versus fiscal 2020 and sets a 42% reduction target by fiscal 2030. Female managers represented 14.8%, compared with 13.7% in fiscal 2023, while the waste recycling rate reached 83%.
Company: Sumitomo Pharma Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2024
Type: Other Report
Pages: 4
Back to company
Sumitomo Pharma Co Ltd
Table Of Material Issues And Kpis
The report presents fiscal 2024 KPI results across product development, human capital, human rights, and environmental initiatives. It reports a 36% reduction in Scope 1+2 GHG emissions versus fiscal 2020 and sets a 42% reduction target by fiscal 2030. Female managers represented 14.8%, compared with 13.7% in fiscal 2023, while the waste recycling rate reached 83%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Fiscal Year
2024
Type
Other Report
Language
English
Pages
File Size
Standards & Assurance
No data available
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
No data available